These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1412790

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF, Wu JP, Luo HY, Daloze PM.
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract] [Full Text] [Related]

  • 3. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 4. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
    Schmidbauer G, Hancock WW, Wasowska BA, Sablinski T, Kupiec-Weglinski JW.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
    [No Abstract] [Full Text] [Related]

  • 5. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P, Chen H, Luo H, Xu D, Shan X, Wu J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract] [Full Text] [Related]

  • 6. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 7. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M, Wang ME, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
    Chen H, Luo H, Daloze P, Xu D, Shan X, St-Louis G, Wu J.
    Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S, Ito T, Kamiike W, Uchikoshi F, Yamamoto S, Nakata S, Shirakura R, Miyata M, Matsuda H, Stepkowski SM.
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D.
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract] [Full Text] [Related]

  • 18. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S, Ito T, Kamiike W, Uchikoshi F, Ito A, Kuhara A, Nakata S, Shirakura R, Miyata M, Matsuda H.
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.